VVP
BLRX

Venture Visionary Partners’s BioLineRX BLRX Stock Holding History

Venture Visionary Partners’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-33
Closed -$1.71K – 584
2022
Q2 		$1.71K Buy
+33
New +$1.83K ﹤0.01% 1555

Other funds holding BLRX

ACM
Altium Capital Management New York $42M AUM
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $6.15B AUM 22.62% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Venture Visionary Partners's BLRX Position: Q3 2022 in Review

Venture Visionary Partners sold out of BioLineRX (BLRX) in Q3 2022, closing a stake of 33 shares — an estimated $1.71K sold.

Venture Visionary Partners first reported a position in BLRX in Q2 2022 and held it in 1 quarter. The position peaked at $1.71K in Q2 2022. 28 funds tracked by Wall St. Rank hold BLRX as of Q3 2022.

  • Venture Visionary Partners reported no remaining BioLineRX position as of Q3 2022 after selling out during the quarter.
  • Venture Visionary Partners sold 33 BioLineRX shares in Q3 2022, an estimated $1.71K.
  • Venture Visionary Partners first reported a position in BioLineRX in Q2 2022 and held it in 1 quarter.
  • Venture Visionary Partners's BioLineRX position peaked at $1.71K in Q2 2022.
  • 28 funds tracked by Wall St. Rank held BioLineRX as of Q3 2022.

Based on Venture Visionary Partners's 13F filing for Q3 2022, filed 14 Nov 2022.